These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8772089)

  • 21. The relationship between liver function and portal pressure: what comes first, the chicken or the egg?
    Triantos C; Samonakis D; Thalheimer U; Patch D; Burroughs A
    J Hepatol; 2005 Jan; 42(1):146-7; author reply 147-8. PubMed ID: 15629521
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemodynamics in patients with liver cirrhosis and portal hypertension syndrome].
    Ershov IuA; Pomelova LA; Kulagina TV; Kislukhin VV; Morozov VA
    Sov Med; 1984; (7):17-23. PubMed ID: 6484727
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of anemia on hemodynamic changes in patients with cirrhosis].
    Denié C; Poynard T; Gadano A; Vachiery F; Soupison T; Elman A; Valla D; Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1997; 21(1):29-33. PubMed ID: 9091387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibiotics can ameliorate circulatory complications of liver cirrhosis].
    Madsen BS; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2011 Aug; 173(35):2127-30. PubMed ID: 21884664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic and renal effects of tadalafil in patients with cirrhosis.
    Kalambokis GN; Kosta P; Pappas K; Tsianos EV
    World J Gastroenterol; 2010 Oct; 16(39):5009-10. PubMed ID: 20954291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Portal hypertensive gastropathy in cirrhosis].
    Møller S; Becker PU; Henriksen JH
    Ugeskr Laeger; 1993 May; 155(19):1480-1. PubMed ID: 8316979
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium].
    Sogni P; Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1999 Jan; 23(1):101-4. PubMed ID: 10219610
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic hemodynamic changes in portal hypertension.
    Ready J; Rector WG
    Semin Gastrointest Dis; 1995 Jul; 6(3):134-9. PubMed ID: 7551970
    [No Abstract]   [Full Text] [Related]  

  • 30. [Propranolol and portal hypertension in cirrhotic patients. Manometric and hemodynamic studies].
    Reding P; Urbain D; Frère D; Thys O; Grivegnée A
    Acta Gastroenterol Belg; 1986; 49(3):324-8. PubMed ID: 3825447
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of portal hypertensive gastropathy: an unresolved issue.
    Lo GH
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1482-3. PubMed ID: 19743994
    [No Abstract]   [Full Text] [Related]  

  • 32. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
    Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
    Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of valsartan on portal hypertension in patients with hepatic cirrhosis].
    Huo LJ; Zhang SJ; Liu Y
    Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):622-3. PubMed ID: 20825720
    [No Abstract]   [Full Text] [Related]  

  • 34. A short cut to predict the clinical response to beta-blocker therapy in cirrhosis?
    Merkel C
    J Hepatol; 2009 Aug; 51(2):268-70. PubMed ID: 19515449
    [No Abstract]   [Full Text] [Related]  

  • 35. Losartan in preascitic cirrhosis.
    Castaño G; Viudez P; Sookoian S
    Am J Gastroenterol; 2004 Nov; 99(11):2282-3. PubMed ID: 15555016
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
    García-Pagán JC; Gracia-Sancho J; Bosch J
    J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug treatment for portal hypertension due to cirrhosis].
    Lebrec D; Benhamou JP
    Gastroenterol Clin Biol; 1982; 6(6-7):542-8. PubMed ID: 6126417
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of rectal mucosal hemodynamics in patients with liver cirrhosis using reflectance spectrophotometry.
    Tezuka T; Akita Y; Yoshikawa N; Mitamura K
    Am J Gastroenterol; 1997 Jun; 92(6):1022-5. PubMed ID: 9177523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.
    Blei AT; Mazhar S; Davidson CJ; Flamm SL; Abecassis M; Gheorghiade M
    J Clin Gastroenterol; 2007; 41 Suppl 3():S323-9. PubMed ID: 17975484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.